| Literature DB >> 36204557 |
Gongshuai Song1,2, Ruofan Shui1, Danli Wang1, Ruosi Fang1, Tinglan Yuan1, Ling Li1, Junli Feng2, Feng Gao3, Qing Shen2, Jinyan Gong1, Fuping Zheng4, Manman Zhang5.
Abstract
The generation and accumulation of amyloid-beta peptide (Aβ1-42) in amyloid plaques are key characteristics of Alzheimer's disease (AD); thus, specific detection of Aβ1-42 is essential for the diagnosis and treatment of AD. Herein, an aptamer-conjugated graphene oxide (Apt-GO) sensor was synthesized by π-π and hydrophobic interactions using thiol poly (ethylene glycol) amine (SH-PEG-NH2) as a spacer unit. Then, it was applied to selective capture of Aβ1-42, and the resulting complex was directly analyzed by surface-assisted laser desorption ionization mass spectrometry (SALDI-MS). The results revealed that the Apt-GO could enhance the detection specificity and reduce non-specific adsorption. This method was validated to be sensitive in detecting Aβ1-42 at a low level in human serum (ca. 0.1 μM) within a linear range from 0.1 to 10 μM. The immobilizing amount of aptamer on the GO was calculated to be 36.1 nmol/mg (RSD = 11.5%). In conclusion, this Apt-GO-based SALDI-MS method was sensitive and efficient in selective extraction and detection of Aβ1-42, which proved to be a good option for early AD diagnosis.Entities:
Keywords: SALDI-MS; amyloid beta-peptide Aβ1–42; aptasensor; graphene oxide; selective enhancement
Year: 2022 PMID: 36204557 PMCID: PMC9530460 DOI: 10.3389/fnagi.2022.993281
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
FIGURE 1Procedure of the aptamer-modified GO nanoparticles fabrication and application for detecting Aβ1–42 coupled with SALDI MS.
FIGURE 2SEM micrographs of graphite (A) and GO (B); FT-IR spectra of GO and aptamer-modified GO nanoparticles (C).
FIGURE 3Schematic analysis of the GO-based aptamer-assisted mass spectrometry analysis. (A) Analysis of analyte ionized on GO without extraction; (B) analysis of analyte extracted with GO and ionized on GO; (C) analysis of analyte extracted with non-covalent-aptamer bound GO and ionized on GO; (D) analysis of analyte extracted with covalent-aptamer bound GO and ionized on GO.
FIGURE 4SALDI MS spectra of Aβ1–42 ([M + H]+, m/z = 4515.7) in the AD cell model. (A) Normal group without aptamer modification and any extraction step; (B) test group extracted with GO; (C) test group extracted with aptamer-modified GO non-covalently; (D) test group extracted with aptamer-modified GO covalently; (E) MS spectrum of Aβ1–42 standard spiked in the human serum sample. Mass spectrometric peaks of Aβ1–42 were labeled with red circles.
FIGURE 5Recycled use of aptamer-modified GO nanoparticles based sensor for Aβ1–42 adsorption.
Detection of the proposed sensor for capture of Aβ1–42 in serum samples.
| Samples | Added (nM) | Found (nM) | Recovery (%) | RSD (%, |
| 1 | 0.1 | 0.0951 ± 0.0023 | 95.10 | 10.5 |
| 2 | 1.0 | 1.0128 ± 0.3677 | 101.28 | 8.2 |
| 3 | 10.0 | 9.8766 ± 0.0715 | 98.77 | 12.6 |